Valuation: Yixintang Pharmaceutical Group Co., Ltd.

Market Cap 620.06Cr 92Cr 80Cr 74Cr 68Cr 128.68Cr 8.79TCr 131.01Cr 882Cr 346.05Cr 4.31TCr 343.88Cr 336.28Cr 15TCr P/E 2026 *
11.6x
P/E 2027 * 9.71x
Enterprise Value 486.09Cr 72Cr 63Cr 58Cr 54Cr 100.87Cr 6.89TCr 102.7Cr 691.43Cr 271.28Cr 3.38TCr 269.58Cr 263.62Cr 12TCr EV / Sales 2026 *
0.27x
EV / Sales 2027 * 0.24x
Free-Float
51.88%
Yield 2026 *
4.39%
Yield 2027 * 4.94%
1 day+3.95%
1 week+5.99%
Current month+12.62%
1 month-3.31%
3 months-13.25%
6 months-20.70%
Current year-16.02%
1 week 9.9
Extreme 9.9
10.95
1 month 9.41
Extreme 9.41
11.22
Current year 9.41
Extreme 9.41
14.8
1 year 9.41
Extreme 9.41
16.03
3 years 9.41
Extreme 9.41
26.96
5 years 9.41
Extreme 9.41
41.55
10 years 9.41
Extreme 9.41
50.1
Manager TitleAgeSince
Chief Executive Officer 48 22/11/2023
President 60 25/11/2019
Director of Finance/CFO 44 22/11/2023
Director TitleAgeSince
Chairman 60 01/06/2009
Chairman 61 01/06/2009
Director/Board Member 44 16/11/2016
Date Insider Type Main position Quantity % Market Cap.
12/05Buy

Founder

13,59,000 0.3397%
12/05Sell

Founder

-27,27,600 0.6818%
11/05Sell

Founder

-88,06,300 2.2012%
Change 5-day change 1-year change 3-year change Capi.($)
+3.95%+5.99%-34.35%-56.68% 92Cr
+1.52%+0.54%-17.27%-27.64% 1.51TCr
+1.82%-3.45%-26.48%-32.80% 680.6Cr
+0.71%-2.31%-20.72%-6.79% 595.48Cr
+3.14%+5.85%-12.10%-30.29% 382.18Cr
-0.05%-1.67%-28.78%-48.24% 316.16Cr
-0.59%-7.44%-38.67%-15.23% 311.89Cr
+8.85%+12.59%+13.36%-27.51% 330.91Cr
-1.54%-0.75%+94.56% - 251.19Cr
0.00%-3.75%-20.63%-3.23% 247.57Cr
Average +1.78%+1.12%-9.11%-27.60% 471.26Cr
Weighted average by Cap. +1.67%+1.17%-13.20%-25.69%

Financials

2026 *2027 *
Net sales 1.8TCr 266.47Cr 232.86Cr 215.27Cr 198.88Cr 374.53Cr 26TCr 381.31Cr 2.57TCr 1.01TCr 13TCr 1TCr 978.78Cr 43TCr 1.92TCr 282.87Cr 247.2Cr 228.52Cr 211.13Cr 397.58Cr 27TCr 404.79Cr 2.73TCr 1.07TCr 13TCr 1.06TCr 1.04TCr 46TCr
Net income 55Cr 8.05Cr 7.03Cr 6.5Cr 6.01Cr 11Cr 773.09Cr 12Cr 78Cr 30Cr 378.56Cr 30Cr 30Cr 1.3TCr 65Cr 9.59Cr 8.38Cr 7.75Cr 7.16Cr 13Cr 921.35Cr 14Cr 92Cr 36Cr 451.15Cr 36Cr 35Cr 1.55TCr
Net Debt -133.97Cr -20Cr -17Cr -16Cr -15Cr -28Cr -1.9TCr -28Cr -190.57Cr -75Cr -930.36Cr -74Cr -73Cr -3.2TCr -163.03Cr -24Cr -21Cr -19Cr -18Cr -34Cr -2.31TCr -34Cr -231.91Cr -91Cr -1.13TCr -90Cr -88Cr -3.9TCr
Logo Yixintang Pharmaceutical Group Co., Ltd.
Yixintang Pharmaceutical Co Ltd, formerly Yunnan Hongxiang Yixintang Pharmaceutical Co Ltd, is a China-based company mainly engaged in pharmaceutical retail chains. The Company is also engaged in major health industries such as pharmaceutical distribution, traditional Chinese medicine industry, medical business, convenience goods, personal care and beauty. The Company's main products include regular decoction pieces, direct oral decoction pieces, active ingredients, ultrafine powders, toxic decoction pieces, and formula granules. The Company mainly operates five major brands: Hongxiang, Shanshang, Huipin, Bendian and Hanzun. The Company mainly operates its businesses in the domestic market.
Employees
34,848
Date Price Change Volume
14/26/14 CN¥10.80 +3.95% 1,44,06,690
13/26/13 CN¥10.39 +2.67% 1,10,42,143
10/26/10 CN¥10.12 +0.70% 65,70,582
09/26/09 CN¥10.05 -2.33% 59,03,393
08/26/08 CN¥10.29 +0.98% 55,12,525
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
10.80CNY
Average target price
14.86CNY
Spread / Average Target
+37.61%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002727 Stock